Trusted electrode performance founded on innovation and quality
We are a specialist manufacturer of bespoke and standard electrodes, known for our design, development and manufacturing excellence.
Bespoke Defibrillator ElectrodesWith the founder of Intelesens creating the world’s first portable defibrillator, our electrodes are well established within the emergency response environment. Available worldwide, our superior quality electrodes are designed and manufactured in the UK, with the EMEA sales and distribution offices based in Athlone, Ireland. We understand that in emergency situations, the operator’s time-critical performance will depend on the reliability and usability of their equipment. For this reason Intelesens’ defibrillator electrodes exclusively use high quality components combined with smart handling design to ensure the highest operator confidence and performance.
Full Electrode Range
Electrodes suitable for adults, children and aviation use.
Excellent Trace Clarity
For optimised signal detection to the patient.
Time and Cost Efficient
With a long shelf life, replacement costs can be reduced.
Fast and easy handling with an out-of-pouch connection.
Bespoke ECG ElectrodesWe specialise in customised electrode design with bespoke features – our in house experienced Product Design Team can create electrodes for innovative vital signs monitors including electrodes that are for 3-lead ECG use, capture respiration waveform as well as activity monitoring.
Excellent Trace Clarity
Intelesens electrodes are designed to maximise signal detection and reduce motion artefact.
Secure Adhesion and Patient Comfort
Minimal skin irritation to the patient when wearing and removing the electrodes.
Special attention to ensure fast and easy handling.
Enhanced Patient Data
Inbuilt functionality including: respiration, tri-axes accelerometer and waveform.
See how Intelesens developed customised electrodes for the world’s first 3-lead ECG and Event monitor, the Zensor™ device.
Quality Production & Guaranteed Supply
With an in-house R&D and manufacturing facility in Belfast, Northern Ireland working closely with the sales and distribution offices in Athlone, Ireland,our fulfilment is assured and responsive to customers requirements.
Intelesens operate a Quality Management System which has successfully been certified to ISO 13485:2016 for medical devices.
The Company is registered with MHRA (Medicines and Healthcare products Regulatory Agency) the UK Competent Authority for placing medical devices on the market within the EU member states as required by the Medical Devices Regulations 2002: Regulation 19. As an OEM (Original Equipment Manufacturer) the Company has experience in manufacturing medical devices that meet both CE and US FDA requirements.
Our Clients & Partners
Innovators with a vision to improve healthcare delivery
Professor John Anderson recognised the need for delivering defibrillator treatment to patients not only within a hospital environment but also the wider community. This concept led him to develop the world’s first portable defibrillator, designed for use outside of the hospital and is now the equipment we routinely see in public places, used to save thousands of lives worldwide.
As an astute businessman, Professor Anderson, created a number of companies, all providing leading-edge medical products in the areas of defibrillators, body surface mapping, implantable atrial fibrillation and remote vital signs monitoring.
In 2001, Professor Anderson partnered with Professor Jim McLaughlin and Professor Eric McAdams, both accomplished medical engineers, who jointly founded Sensor Technologies and Devices in 2001, later to become Intelesens Ltd.
With its continued links into a number of world-leading research institutes, Intelesens has an established Intellectual Property (IP) and product pipeline of new medtech innovations.
In August 2017, Renew Health Ltd acquired the Intelesens business, and its portfolio of intelligent, wearable, non-invasive, vital signs monitoring devices for the hospital and home patient monitoring markets as well as its electrode design and manufacturing expertise.
Due to significant demand over the last two years, the Intelesens production capacity will undergo an expansion programme, increasing output by 30% by the end of 2019, ensuring consistent supply of electrodes to its established and new partners.